FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068498 [Registered on: 06/06/2024] Trial Registered Prospectively
Last Modified On: 01/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Supplementation]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing Pearl Millet and Ready-to-Use Foods in Malnourished children 
Scientific Title of Study   Effect of Pearl millet (Bajra) supplementation VS Ready to use supplementary food on the growth of children with moderate acute malnutrition 
Trial Acronym  NIL  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ishani Jha 
Designation  Post Graduate Resident 
Affiliation  University College of Medical Sciences  
Address  Department of Pediatrics University College of Medical Sciences & Guru Teg Bahadur Hospital East Delhi 110095 India

North East
DELHI
110095
India 
Phone  8130028757  
Fax    
Email  ishanijha@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manish Narang 
Designation  Director Professor Department of Pediatrics 
Affiliation  University College of Medical Sciences & Guru Teg Bahadur Hospital  
Address  Department of Pediatrics University College of Medical Sciences & Guru Teg Bahadur Hospital East Delhi 110095 India

East
DELHI
110095
India 
Phone  9811036569  
Fax    
Email  manish_2710@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ishani Jha 
Designation  Post graduate Department of Pediatrics 
Affiliation  University College of Medical Sciences & Guru Teg Bahadur Hospital  
Address  Room no 10, Paeds OPD, Department of Pediatrics University College of Medical Sciences & Guru Teg Bahadur Hospital East Delhi 110095 India

East
DELHI
110095
India 
Phone  8130028757  
Fax    
Email  ishanijha@gmail.com  
 
Source of Monetary or Material Support  
University College of Medical Sciences 
 
Primary Sponsor  
Name  University College of Medical Sciences 
Address  Dilshad Garden, East Delhi 110095 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ishani Jha  UCMS & GTB Hospital  University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, New Delhi- 110095 North East DELHI
East
DELHI 
8130028757

ishanijha@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Human Researc University College of Medical Sciences University of Delhi Delhi 110095   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E440||Moderate protein-calorie malnutrition,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Pearl millet (Bajra) supplementation  Daily Pearl millet (Bajra)supplementation for three months 
Comparator Agent  Ready to use supplementary food   Daily RUSF supplementation for three months 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  5.00 Year(s)
Gender  Both 
Details  Children (aged 2 - 5 years) with moderate acute malnutrition according to the WHO criteria 
 
ExclusionCriteria 
Details  Children with known chronic systemic disease, congenital malformations, chromosomal anomalies, inborn errors of metabolism, already on / history of iron supplementation in preceding 4 weeks, children with mothers having understanding issues due to language barrier
• Children with mothers not having primary education
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the recovery rate in 2-5 years old children with moderate acute malnutrition receiving Pearl millet (Bajra)-based diet supplementation with those receiving RUSF   At baseline, 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
(1) Change in hemoglobin level (2) Average time required for recovery
(3) Proportion of children relapsed at 6 months from enrolment
(4) Compliance and caregiver satisfaction (Likert scale) 
At baseline, 3 months , 6 months 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study aims to evaluate the effect of pearl millet supplementation on the growth of 2–5-year-old children with moderate acute malnutrition (MAM). It primarily compares the recovery rate, measured by the change in weight-for-height Z-score, between children receiving pearl millet-based supplementation and those receiving ready-to-use supplementary food (RUSF) over three months. Secondary objectives include comparing changes in hemoglobin levels, recovery time, relapse rates within six months, and caregiver satisfaction. Conducted at UCMS & GTB Hospital in Delhi, this open-label randomized controlled trial involves 120 children, divided into two groups. Anthropometric measurements and hemoglobin levels will be assessed at baseline and after three months, with follow-ups to monitor progress and compliance. 
Close